|
ATG5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.13280000000071E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.25759999997288E-06 |
| Normal-vs-Stage2 |
1.054380E-02 |
| Normal-vs-Stage3 |
2.221200E-01 |
| Normal-vs-Stage4 |
9.870200E-01 |
| Stage1-vs-Stage2 |
4.469400E-01 |
| Stage1-vs-Stage3 |
4.016100E-02 |
| Stage1-vs-Stage4 |
2.238300E-02 |
| Stage2-vs-Stage3 |
3.946200E-01 |
| Stage2-vs-Stage4 |
1.566590E-01 |
| Stage3-vs-Stage4 |
4.867400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.79759999999951E-05 |
| Normal-vs-AfricanAmerican |
4.640200E-03 |
| Normal-vs-Asian |
6.355600E-01 |
| Caucasian-vs-AfricanAmerican |
4.876200E-01 |
| Caucasian-vs-Asian |
4.288000E-01 |
| AfricanAmerican-vs-Asian |
5.760200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.53120999999423E-05 |
| Normal-vs-Female |
1.433730E-02 |
| Male-vs-Female |
5.047900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.790870E-04 |
| Normal-vs-Extreme_Weight |
5.48499999974972E-07 |
| Normal-vs-Obese |
1.520370E-02 |
| Normal-vs-Extreme_Obese |
3.913900E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.391200E-01 |
| Normal_Weight-vs-Obese |
1.254760E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.660800E-01 |
| Extreme_Weight-vs-Obese |
2.811700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.706800E-01 |
| Obese-vs-Extreme_Obese |
7.254600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.978400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.460400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.89827000000031E-05 |
| Normal-vs-Age(81-100Yrs) |
2.92229999998561E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.027630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.084200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.160500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.479230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.556480E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.554100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.94449999999713E-05 |
| Normal-VS-Type2 PRCC |
4.046100E-04 |
| Normal-VS-KIRP CIMP |
2.095400E-01 |
| Normal-VS-Unclassified PRCC |
2.583700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.539200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.371990E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.603800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.922700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.628200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.323300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67783999999171E-05 |
| Normal-vs-N1 |
5.759600E-01 |
| Normal-vs-N2 |
1.601920E-03 |
| N0-vs-N1 |
1.024430E-04 |
| N0-vs-N2 |
3.677200E-01 |
| N1-vs-N2 |
2.995600E-02 |
|
|
